These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11431204)

  • 21. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Corrigan G; Stevens PE
    Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
    Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
    Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
    Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ
    Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
    Bosque López MJ; Garrido Durán C; Ginard Vicens D; Munar Vila MA; Vanrell Garau M; Mariño Méndez Z; Gayà Cantallops J
    Gastroenterol Hepatol; 2009 Jan; 32(1):29-31. PubMed ID: 19174096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.
    Foster RA; Zander DS; Mergo PJ; Valentine JF
    Inflamm Bowel Dis; 2003 Sep; 9(5):308-15. PubMed ID: 14555914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
    Laboudi A; Makdassi R; Cordonnier C; Fournier A; Choukroun G
    Nephrologie; 2002; 23(7):343-7. PubMed ID: 12500420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Frandsen NE; Saugmann S; Marcussen N
    Nephron; 2002 Sep; 92(1):200-2. PubMed ID: 12187103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis.
    Sinico RA; Sabadini E; Maresca AM
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S104. PubMed ID: 16859609
    [No Abstract]   [Full Text] [Related]  

  • 32. Interstitial nephritis from mesalazine: case report and literature review.
    Arend LJ; Springate JE
    Pediatr Nephrol; 2004 May; 19(5):550-3. PubMed ID: 15007714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute interstitial nephritis due to mesalazine.
    Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
    Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesalamine in the treatment of active Crohn's disease.
    Dignass A; Marteau P
    Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG; McDonald JW
    Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
    [No Abstract]   [Full Text] [Related]  

  • 36. Celecoxib-induced acute interstitial nephritis.
    Henao J; Hisamuddin I; Nzerue CM; Vasandani G; Hewan-Lowe K
    Am J Kidney Dis; 2002 Jun; 39(6):1313-7. PubMed ID: 12046048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
    Galvão Braga C; Martins J; Arantes C; Ramos V; Vieira C; Salgado A; Magalhães S; Correia A
    Rev Port Cardiol; 2013 Sep; 32(9):717-20. PubMed ID: 23993290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
    Bjerrum JT; Munck LK; Nielsen OH
    Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute and subacute renal failure].
    Praxis (Bern 1994); 2008 Oct; 97(20):1057-64; quiz 1065-6. PubMed ID: 18850521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.